Neuroscience

Edited by: Steve Bunk M. Ankarcrona, J.M. Dypbukt, E. Bonfoco, B. Zhivotovsky, S. Orrenius, S.A. Lipton, P. Nicotera, "Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function," Neuron, 15:961-73, 1995. (Cited in 120 papers through October 1997) Comments by Stuart A. Lipton, Cerebrovascular and NeuroScience Research Institute, Brigham and Women's Hospital and Program in Neuroscience, Harvard Medical School; and Pierluigi Nicotera, Molecular To

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Edited by: Steve Bunk
M. Ankarcrona, J.M. Dypbukt, E. Bonfoco, B. Zhivotovsky, S. Orrenius, S.A. Lipton, P. Nicotera, "Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function," Neuron, 15:961-73, 1995. (Cited in 120 papers through October 1997)

Comments by Stuart A. Lipton, Cerebrovascular and NeuroScience Research Institute, Brigham and Women's Hospital and Program in Neuroscience, Harvard Medical School; and Pierluigi Nicotera, Molecular Toxicology Program, University of Konstanz, Germany

When a region of an injured brain is deprived of blood and oxygen, there are two ways the cells can die, by necrosis or by apoptosis. The mode of death makes a big difference to surrounding tissue. In the study that prompted this paper, a multinational team discovered that the functioning of a brain neuron's mitochondria-the energy-producing organelles outside the nucleus-is the critical determinant of how the cell dies during blood-deprived or ischemic brain injury, as well as ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies